Biotechnology
VYNE
0.3478
price down icon2.39%   -0.0079
 

Vyne Therapeutics Inc (VYNE)
full-star
loading
Overview News Price History Financials Discussions Forecast Stock Split
Vyne Therapeutics Inc stock is traded at $0.3478, with a volume of 849.78K. It is down -2.39% in the last 24 hours and down -6.74% over the past month. VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
See More
Previous Close:
$0.3557
Open:
$0.3569
24h Volume:
849.78K
Relative Volume:
0.37
Market Cap:
$8.84M
Revenue:
$476.00K
Net Income/Loss:
$-38.52M
P/E Ratio:
-0.3847
EPS:
-0.9041
Net Cash Flow:
$-39.89M
1W Performance:
-3.82%
1M Performance:
-6.74%
6M Performance:
-74.66%
1Y Performance:
-86.90%
1-Day Range:
Value
$0.347
$0.3655
1-Week Range:
Value
$0.331
$0.389
52-Week Range:
Value
$0.2805
$4.30

Vyne Therapeutics Inc Stock (VYNE) Company Profile

Name
Name
Vyne Therapeutics Inc
Name
Sector
Healthcare (1139)
Name
Industry
Biotechnology (635)
Name
Phone
800-775-7936
Name
Address
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Name
Employee
13
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
VYNE's Discussions on Twitter

Compare VYNE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VYNE
Vyne Therapeutics Inc
 0.3472 9.06M 476.00K -38.52M -39.89M -0.9041
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 425.08 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 641.99 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 432.26 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
 822.85 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 183.78 40.44B 447.02M -1.18B -868.57M -6.1812

Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-31-25 Downgrade BTIG Research Buy → Neutral
Nov-18-24 Initiated BTIG Research Buy
Dec-06-21 Resumed H.C. Wainwright Buy

Vyne Therapeutics Inc Stock (VYNE) Latest News

pulisher
11:32 AM

Healthy Upside Potential: VYNE Therapeutics Inc (VYNE) - setenews.com

11:32 AM
pulisher
11:16 AM

Short Interest in VYNE Therapeutics Inc. (NASDAQ:VYNE) Declines By 29.5% - Defense World

11:16 AM
pulisher
09:35 AM

Can swing trading help recover from VYNE Therapeutics Inc. losses2025 Price Action Summary & High Return Trade Guides - newser.com

09:35 AM
pulisher
09:27 AM

Why analysts remain bullish on VYNE Therapeutics Inc. stock2025 Bull vs Bear & Safe Capital Growth Tips - newser.com

09:27 AM
pulisher
09:25 AM

What Wall Street predicts for VYNE Therapeutics Inc. stock price2025 Institutional Moves & Free Daily Entry Point Trade Alerts - newser.com

09:25 AM
pulisher
08:42 AM

Why VYNE Therapeutics Inc. stock could be next big winnerJuly 2025 Highlights & Technical Entry and Exit Alerts - newser.com

08:42 AM
pulisher
08:35 AM

Vyne Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView

08:35 AM
pulisher
08:02 AM

Signal strength of VYNE Therapeutics Inc. stock in tech scanners2025 Earnings Surprises & Safe Entry Point Alerts - newser.com

08:02 AM
pulisher
05:51 AM

What high frequency data says about VYNE Therapeutics Inc.2025 Investor Takeaways & Short-Term Trading Alerts - newser.com

05:51 AM
pulisher
03:51 AM

Tools to monitor VYNE Therapeutics Inc. recovery probabilityWeekly Stock Report & Risk Controlled Swing Alerts - newser.com

03:51 AM
pulisher
03:30 AM

What earnings revisions data tells us about VYNE Therapeutics Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com

03:30 AM
pulisher
Nov 02, 2025

Understanding VYNE Therapeutics Inc.’s price movement2025 Volatility Report & Free Technical Confirmation Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can technical indicators confirm VYNE Therapeutics Inc.’s reversal2025 Trade Ideas & Scalable Portfolio Growth Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why VYNE Therapeutics Inc. stock is seen as undervaluedProfit Target & Consistent Return Investment Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is VYNE Therapeutics Inc. stock supported by innovation pipelineJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Using R and stats models for VYNE Therapeutics Inc. forecastingJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Is VYNE Therapeutics Inc. showing signs of accumulationTrade Ideas & Verified Stock Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Will VYNE Therapeutics Inc. stock benefit from sector rotationJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com

Oct 30, 2025

Vyne Therapeutics Inc Stock (VYNE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Similar to VYNE

biotechnology RPRX
$37.49
price down icon 0.27%
biotechnology GMAB
$28.64
price up icon 0.10%
biotechnology INCY
$100.80
price up icon 8.05%
biotechnology BNTX
$104.06
price up icon 0.13%
biotechnology ONC
$312.04
price up icon 0.52%
biotechnology INSM
$183.82
price down icon 3.02%
Open in Yahoo | Open in Google | Open in Finviz | Open in MarketWatch | Open in EDGAR | Open in Reuters
Cap:     |  Volume (24h):